the impact that Sarum Life Sciences is having in an industry subject to enormous change.
“We are delighted to be named a Top 5 agency for Life Sciences PR & Marketing. We take enormous pride in the work we do at Sarum, so it is immensely rewarding to be recognized in this way,” says Carina Birt, Founder and Lead Strategist, Sarum Life Sciences.
“Life Sciences companies are facing unprecedented new opportunities and challenges in the wake of the COVID-19 pandemic when speed to market with the latest vaccines, therapies and treatments was paramount and the Regulatory environment adapted to enable it. The market is volatile too, characterized by significant merger and acquisition activity, and the entry of new biotechs, medtech innovators, industry disruptors and ambitious startups at ever shorter intervals. Against this backdrop, agility, creativity and topical thought leadership are essential if Life Sciences brands and their service partners are to rise above the market noise,” explains Birt.
“We monitor the market closely and continuously, tracking the latest emerging trends, challenges and opportunities, which we’re able to propose new and thought-provoking rather than well-worn themes to our clients and editors, and it’s this approach that appeals so strongly to our clients. The freshness of our ideas, and our deep familiarity with the industry, its concerns and its language, mean we can hit the ground running with any new opportunity – and, press-wise, the doors just open.”
With 25+ experience of tracking and proactively guiding companies through their public responses to the industry’s evolution and disruption, and building on long-established relationships with the Life Sciences press globally, Sarum Life Sciences has helped differentiate and give new voice to some of the most important and exciting industry brands, old and new.
Engaged by major consultants and industry watchers including Deloitte, Gens & Associates and Biopharma Excellence, as well as Life Sciences tech and service specialists including Arriello, Schlafender Hase, Aris Global, Rephine and fme, Sarum Life Sciences delivers both comprehensive creative B2B marketing and PR campaigns, plus provocative thought leadership content that reliably and rapidly gains traction globally. From cross-industry debates on the hottest topical issues, including Biopharma Excellence’s Science Huddle thinktanks, to research-led papers on the latest regulatory investments companies are making, Sarum Life Sciences specialises in stimulating and advancing the conversation.
Sarum Life Sciences doesn’t shy away from challenging its clients, either. “If there is a meatier topic, a new angle, we’ll know it or find it and propose it,” says Birt. “Proactive market analysis, added to our experienced journalists’ everyday contact with leaders across the market, means we never miss a trick.”
For clients with high-level messaging needs, Sarum refreshes those companies’ marketing language, to produce lighter, sharper, clearer, and more accessible brand stories that resonate with their target audience. For companies with regulatory, pharmacovigilance, quality, or safety-related offerings, Sarum leverages deep industry insights to convey a brand and product story that attracts the attention of purchase influencers and potential customers.
Sarum Life Sciences has been pivotal to the success of many Life Sciences-oriented marcomms strategies, including the conception and execution of Biopharma Excellence’s Science Huddle debates was critical in propelling the brand straight to the forefront of the industry. Additionally, the quarterly thought leadership panel focuses on complex industry challenges, with representation from across the Life Sciences ecosystem.
A female-founded and independently-owned company, Sarum Life Sciences continues to look for new and fresh ways to help clients capitalize on burgeoning market opportunities. Pharma Tech Outlook is a respected enterprise technology magazine and knowledge platform for the Life Sciences industry.